The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety profile of nivolumab administered as 30-minute (min) infusion: Analysis of data from CheckMate 153.
 
David Michael Waterhouse
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly
 
Leora Horn
Honoraria - Biodesix
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Merck; Puma Biotechnology; Xcovery
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst)
 
Craig H. Reynolds
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Lilly
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Lilly
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Genentech; Lilly
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Lilly
 
David R. Spigel
Stock and Other Ownership Interests - Foundation Medicine; Illumina
Consulting or Advisory Role - AstraZeneca; Biodesix; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech/Roche; Lilly; Novartis; Pfizer
Speakers' Bureau - Novartis
Research Funding - Amgen (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); BIND Biosciences (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); CytRx Corporation (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); ImClone Systems (Inst); Immunogen (Inst); Lilly (Inst); Novartis (Inst); Oncogenex (Inst); OncoMed (Inst); Peregrine Pharmaceuticals (Inst); Pfizer (Inst); University of Texas Southwestern Medical Center - Simmons Cancer Center (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Biodesix; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech/Roche; Lilly; Novartis; Pfizer
 
Jason Claud Chandler
Consulting or Advisory Role - Bristol-Myers Squibb; Caris MPI; Janssen
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Caris MPI; Janssen
 
Tarek Mekhail
Honoraria - Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
 
Mohamed K. Mohamed
No Relationships to Disclose
 
Ben C. Creelan
Honoraria - Boehringer Ingelheim
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb
Research Funding - Boehringer Ingelheim
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Kenneth Bruce Blankstein
No Relationships to Disclose
 
Petros Nikolinakos
Consulting or Advisory Role - Boehringer Ingelheim; Exelixis; Lilly
Speakers' Bureau - Boehringer Ingelheim
 
Michael McCleod
No Relationships to Disclose
 
Ang Li
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Ian M. Waxman
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Nivedita Aanur
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Shruti Agrawal
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb